Atlas Trials

PK and Dose Escalation and Expansion Study of DST-2970

Clinical trial NCT04291664 · TERMINATED

Trial details

NCT number
NCT04291664
Sponsor
DisperSol Technologies, LLC
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Prostate Cancer
Start date
2020-01-31
Primary completion
2023-01-27
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.